Kelly DL - Search Results

1

Risk-taking in schizophrenia and controls with and without cannabis dependence.

Fischer BA, McMahon RP, Kelly DL, Wehring HJ, Meyer WA, Feldman S, Carpenter WT, Gorelick DA. Fischer BA, et al. Among authors: kelly dl. Schizophr Res. 2015 Feb;161(2-3):471-7. doi: 10.1016/j.schres.2014.11.009. Epub 2014 Nov 22. Schizophr Res. 2015. PMID: 25467541 Free PMC article.

2

Olanzapine response in treatment-refractory schizophrenic patients with a history of substance abuse.

Conley RR, Kelly DL, Gale EA. Conley RR, et al. Among authors: kelly dl. Schizophr Res. 1998 Sep 7;33(1-2):95-101. doi: 10.1016/s0920-9964(98)00062-0. Schizophr Res. 1998. PMID: 9783349

3

Differential olanzapine plasma concentrations by sex in a fixed-dose study.

Kelly DL, Conley RR, Tamminga CA. Kelly DL, et al. Schizophr Res. 1999 Nov 30;40(2):101-4. doi: 10.1016/s0920-9964(99)00053-5. Schizophr Res. 1999. PMID: 10593449

4

Novel factor-based symptom scores in treatment resistant schizophrenia: implications for clinical trials.

McMahon RP, Kelly DL, Kreyenbuhl J, Kirkpatrick B, Love RC, Conley RR. McMahon RP, et al. Among authors: kelly dl. Neuropsychopharmacology. 2002 Apr;26(4):537-45. doi: 10.1016/S0893-133X(01)00387-6. Neuropsychopharmacology. 2002. PMID: 11927178

5

Circumstances of suicide among individuals with schizophrenia.

Kreyenbuhl JA, Kelly DL, Conley RR. Kreyenbuhl JA, et al. Among authors: kelly dl. Schizophr Res. 2002 Dec 1;58(2-3):253-61. doi: 10.1016/s0920-9964(01)00379-6. Schizophr Res. 2002. PMID: 12409166

6

Rehospitalization risk with second-generation and depot antipsychotics.

Conley RR, Kelly DL, Love RC, McMahon RP. Conley RR, et al. Among authors: kelly dl. Ann Clin Psychiatry. 2003 Mar;15(1):23-31. doi: 10.1023/a:1023276509470. Ann Clin Psychiatry. 2003. PMID: 12839430

7

The efficacy of high-dose olanzapine versus clozapine in treatment-resistant schizophrenia: a double-blind crossover study.

Conley RR, Kelly DL, Richardson CM, Tamminga CA, Carpenter WT Jr. Conley RR, et al. Among authors: kelly dl. J Clin Psychopharmacol. 2003 Dec;23(6):668-71. doi: 10.1097/01.jcp.0000096246.29231.73. J Clin Psychopharmacol. 2003. PMID: 14624201 Clinical Trial. No abstract available.

8

Deaths from diabetic ketoacidosis after long-term clozapine treatment.

Wehring HJ, Kelly DL, Love RC, Conley RR. Wehring HJ, et al. Among authors: kelly dl. Am J Psychiatry. 2003 Dec;160(12):2241-2. doi: 10.1176/appi.ajp.160.12.2241-a. Am J Psychiatry. 2003. PMID: 14638600 No abstract available.

9

Adverse effects and laboratory parameters of high-dose olanzapine vs. clozapine in treatment-resistant schizophrenia.

Kelly DL, Conley RR, Richardson CM, Tamminga CA, Carpenter WT Jr. Kelly DL, et al. Ann Clin Psychiatry. 2003 Sep-Dec;15(3-4):181-6. doi: 10.1023/b:acli.0000008171.90644.f8. Ann Clin Psychiatry. 2003. PMID: 14971863 Clinical Trial.

10

Atypical antipsychotic use in a state hospital inpatient adolescent population.

Kelly DL, Love RC, MacKowick M, McMahon RP, Conley RR. Kelly DL, et al. J Child Adolesc Psychopharmacol. 2004 Spring;14(1):75-85. doi: 10.1089/104454604773840517. J Child Adolesc Psychopharmacol. 2004. PMID: 15142394

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

426 results

Search Page

Filters